Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Detlev Riesner, Werner Brandt, Elaine Mardis, Steve Allen, and More

Premium

Qiagen Co-Founder Detlev Riesner, has retired as Chairman of the Supervisory Board. He served on the board since 1996 and as chairman since 2003. Werner Brandt will become the new chairman. All other members of the supervisory board — Stéphane Bancel, Metin Colpan, Manfred Karobath, Lawrence Rosen, and Elizabeth Tallett — are being proposed for re-election to one-year terms at the annual general meeting. In addition, Elaine Mardis is being proposed for election as a new member. Mardis is co-director of the Genome Institute at Washington University in St. Louis. She is the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, and also is a professor in the department of genetics at Wash U.


DNA Electronics has appointed Steve Allen to the position of COO. Prior to joining DNA Electronics, Allen was managing director of LGC Forensics. He has also served as managing director for the consulting company i2r Limited and held various positions at PerkinElmer. In addition, Allen was formerly a board member and advisor to Solexa, before Illumina bought it.


The Broad Institute has appointed two new members to its senior leadership team, including Samantha Singer as chief operating officer and Clare Midgley as chief communications officer.

Singer formerly was VP of corporate strategy and chief of staff for the CEO at Biogen Idec. As COO at the Broad she will oversee the institute's human resources, finance, facilities, and IT teams, as well as the office of strategic alliances and partnering.

Midgley is a communications strategy consultant who formerly was VP of global corporate affairs at Millennium Pharmaceuticals.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.